SCHEMBL16629016

SCHEMBL16629016

Cc1ccn2ncc(I)c2n1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMPD3 Q9NY59 8/20 0.42
TYK2 P29597 2/20 0.41
HSD11B1 P28845 1/20 0.36
PDE2A O00408 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.34
HTR6 P50406 3/20 0.33
SCN5A Q14524 1/20 0.33
CCNT1 O60563 1/20 0.33
FLT3 P36888 1/20 0.33
PIK3CA P42336 1/20 0.33
CDK7 P50613 1/20 0.33
CDK9 P50750 1/20 0.33
TGFBR1 P36897 2/20 0.33
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31
JAK3 P52333 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10308911 0.80 SCN5A (0.48) SMPD3TYK2HSD11B1PDE2AIRAK4
SCHEMBL15306540 0.78 SMPD3 (0.40) SMPD3TYK2HSD11B1PDE2AIRAK4
SCHEMBL13976071 0.78 SMPD3 (0.40) SMPD3TYK2HSD11B1PDE2AIRAK4
SCHEMBL29962126 0.77 PIM1 (0.49) SMPD3TYK2JAK2JAK1JAK3
SCHEMBL15715204 0.77 TYK2 (0.47) SMPD3TYK2HSD11B1PDE2AHTR6
SCHEMBL7460458 0.77 SMPD3 (0.67) SMPD3TYK2HSD11B1PDE2A
SCHEMBL15715208 0.77 SMPD3 (0.42) SMPD3TYK2HSD11B1PDE2AIRAK4
Hydrochloric Acid SCHEMBL29243906 0.76 SMPD3 (0.65) SMPD3TYK2HSD11B1PDE2A
SCHEMBL15715199 0.73 TGFBR1 (0.55) SMPD3TYK2TGFBR1
SCHEMBL15159109 0.73 PDE2A (0.39) SMPD3TYK2HSD11B1PDE2AIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019023417-A1 MACROCYCLIC COMPOUNDS AND USES THEREOF TP THERAPEUTICS, INC. (US) 2019-01-31 WO disclosed
WO-2016054491-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2016-04-07 WO disclosed
WO-2015143012-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF PI3K-GAMMA MEDIATED DISORDERS INFINITY PHARMACEUTICALS, INC. (US) 2015-09-24 WO disclosed
WO-2015051241-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2015-04-09 WO disclosed